Clinical Guest Contributors

  1. How To Avoid Hazards And Map A Safer, Smarter Path For AI, Part 1 7/15/2025

    Even with a clear destination with real rewards, the AI journey is full of hidden potholes, unexpected detours, and costly wrong turns. Tanisha Patel and Vincent Puglia explore several considerations when integrating AI in clinical research.

  2. From Protocol To People: Teva's Patient-First Clinical Trials Approach 7/14/2025

    Teva Pharmaceuticals' Head of Global Early Clinical Development Eran Harary, MD, shares how the company approaches drug development by getting patient input early and often.

  3. A Guide To Guidelines: How ICH And Others Help Us Conduct Better Trials 7/11/2025

    Guidelines abound in clinical research. So, how should sponsor companies and partners think about their role in ensuring compliance? Consultant Kamila Novak explores their importance.

  4. How An Australia-First Strategy Cut 63% From Our R&D Spend 7/10/2025

    Etira CEO Russell Hayward explains how conducting the company's early-stage trials in Australia has yielded big savings, shortened timelines, and produced FDA-ready data.

  5. Imunon Talks Passionate PIs, Endpoint Selection In Frontline Ovarian Cancer Trials 7/9/2025

    IMUNON CEO Stacy Lindborg, Ph.D. details the company’s successes in site selection, as well as trial design and execution, in Phase 2 and 3 trials for IMNN-001, a frontline treatment for ovarian cancer.

  6. Dear Pharma, The Creator Economy Is NOT Only For Beauty 7/7/2025

    Empactful Ventures CEO Denise N. Bronner has a message for pharma when it comes to influencer marketing: Adapt or become invisible. Here, she details the hazards of overlooking this powerful media channel.

  7. 2 Challenges In Designing A Clinical Trial Exploring Personalized Elimination Diets 7/3/2025

    Vibrant Wellness clinical coordinator Suzanne Barker, MS, RDN, LDN, CGP, discusses how they faced and resolved two key issues when conducting a food sensitivity clinical trial.

  8. Accurate Diagnosis And Enrollment Criteria Improve Intracerebral Hemorrhage Research 7/2/2025

    CEO Marc Deschamps shares how ischemic stroke treatment has overshadowed that of intracerebral hemorrhage, negatively impacting recruitment for ICH clinical trials. To turn the tide, he advocates for accurate diagnoses, more specialized care, and less restrictive enrollment criteria.

  9. Hey, What's The Big Idea? Patient Enrollment Utterly Reimagined, That's What 7/1/2025

    What do air traffic control, nuclear power plants, and aircraft carriers have in common? Patient recruitment expert Tatty Scott argues clinical researchers should look at these industries to inspire more precise trial execution.

  10. Breaking Free From The Acronym Soup: Rethinking The Role Of Technology In Clinical Trials 6/30/2025

    Ascendis Pharma's Ivanna Rosendal details how clinical systems hinder clinical trial execution and why we should rethink how technology can support our trials.